Biological Mechanisms of Chronic Wound and Diabetic Foot Healing: The Role of Collagen

1. Rumyantseva S.A., Stupin V.A., Silina E.V. Multidisciplinary approaches to the treatment of ischemia and hypoxia syndromes in patients with diabetes mellitus. Moscow. MIA-PRINT. 2011. 88 pp.Search in Google Scholar

2. Rumjanceva S.A., Oganov R.G., Stupin V.A., Silina E.V., Orlova A.S., Bolevich S.B., Afanas’ev V.V., Kabaeva E.N., Volik S.A. Problems and prospects of correction of intermediate metabolism in patients with vascular comorbidity. Rational pharmacotherapy in cardiology. 2013; 9(3):316-322.10.20996/1819-6446-2013-9-3-316-322Search in Google Scholar

3. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005;366:1736–1743.10.1016/S0140-6736(05)67700-8Search in Google Scholar

4. Bakker K., Apelqvist J., Schaper N.C. Practical guidelines on the management and prevention of the diabetic foot 2010. Diabetes Metab Res Rev. 2012;28(1):225–231.10.1002/dmrr.2253Open DOISearch in Google Scholar

5. Game F.L, Hinchliffe R.J., Apelqvist J., Armstrong D.G., Bakker K., Hartemann A., Löndahl M., Price P.E., Jeffcoate W.J. International Working Group on Diabetic Foot. Specific guidelines on wound and woundbed management. 2011. Diabetes Metab Res Rev. 2012;28(Suppl 1):232–233.10.1002/dmrr.2250Search in Google Scholar

6. Naves C.C. The Diabetic Foot: A Historical Overview and Gaps in Current Treatment // Adv Wound Care (New Rochelle). 2016;5:191-197.10.1089/wound.2013.0518Search in Google Scholar

7. Wrobel J., MacEachern M., Boles B. Collagen-based wound dressings for the treatment of diabetes-related foot ulcers: a systematic review. Diabetes Metab Syndr Obes. 2013;6:17-29.10.2147/DMSO.S36024Search in Google Scholar

8. van Gent W.B., Wilschut E.D., Wittens C. Management of venous ulcer disease. BMJ (Clin Res Ed). 2010;341:604510.1136/bmj.c6045Search in Google Scholar

9. Gillespie D.L.; Writing Group III of the Pacific Vascular Symposium 6, Kistner B, Glass C, Bailey B, Chopra A, Ennis B, Marston B, Masuda E, Moneta G, Nelzen O, Raffetto J, Raju S, Vedantham S, Wright D, Falanga V. Venous ulcer diagnosis, treatment, and prevention of recurrences. J Vasc Surg. 2010;52(5 Suppl):8S-14S.10.1016/j.jvs.2010.05.068Search in Google Scholar

10. Begma A.N., Begma I.V., Homjakova E.K. Experience in the use of collagen dressings and sponges meturakol in surgical practice. Rossijskij medicinskij zhurnal. 2014;17:1248-1251 (in Rus)Search in Google Scholar

11. Nicolaides A.N.; Cardiovascular Disease Educational and Research Trust; European Society of Vascular Surgery; The International Angiology Scientific Activity Congress Organization; International Union of Angiology; Union Internationale de Phlebologie at the Abbaye des Vaux de Cernay. Investigation of chronic venous insufficiency: A consensus statement (France, March 5-9, 1997). Circulation. 2000;102(20):E126-63.10.1161/01.CIR.102.20.e126Search in Google Scholar

12. Zhang P., Lu J., Jing Y., Tang S., Zhu D., B.Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017;49(2):106-116.10.1080/07853890.2016.1231932Open DOISearch in Google Scholar

13. Singh N., Armstrong D.G., Lipsky B.A. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293:217–228.10.1001/jama.293.2.217Search in Google Scholar

14. Bruhn-Olszewska B., Korzon-Burakowska A., Gabig- Ciminska M., Olszewski P., Wegrzyn A., Jakobkiewicz- Banecka J. Molecular factors involved in the development of diabetic foot syndrome Acta Biochimica Pol. 2012;59:507-513.10.18388/abp.2012_2085Search in Google Scholar

15. Lepantalo M., Apelqvist J., Setacci C., Ricco JB., de Donato G., Becker F., Robert-Ebadi H., Cao P., Eckstein H.H., De Rango P., Diehm N., Schmidli J., Teraa M., Moll F.L., Dick F., Davies A.H. Chapter V: diabetic foot. Eur J Vasc Endovas Surg. 2011;42(suppl 2):S60-S74.10.1016/S1078-5884(11)60012-9Search in Google Scholar

16. Ricco J.B., Thanh Phong L., Schneider F., Illuminati G., Belmonte R., Valagier A., Régnault De La Mothe G. The diabetic foot: a review. J Cardiovasc Surg. 2013;54:755-762.Search in Google Scholar

17. Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K, Edmonds M, Holstein P, Jirkovska A, Mauricio D, Ragnarson Tennvall G, Reike H, Spraul M, Uccioli L, Urbancic V, Van Acker K, van Baal J, van Merode F, Schaper N. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia. 2007;50:18–25.10.1007/s00125-006-0491-1Open DOISearch in Google Scholar

18. Prompers L, Schaper N, Apelqvist J, Edmonds M, Jude E, Mauricio D, Uccioli L, Urbancic V, Bakker K, Holstein P, Jirkovska A, Piaggesi A, Ragnarson-Tennvall G, Reike H, Spraul M, Van Acker K, Van Baal J, Van Merode F, Ferreira I, Huijberts M. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetologia. 2008;51:747–755.10.1007/s00125-008-0940-0Open DOISearch in Google Scholar

19. Wukich D.K., Ahn J., Raspovic K.M., Gottschalk F.A., La Fontaine J., Lavery L.A. Comparison of Transtibial Amputations in Diabetic Patients With and Without End-Stage Renal Disease. Foot Ankle Int. 2017;1:P. 1071100716688073.10.1177/1071100716688073Search in Google Scholar

20. Forsythe R.O., Brownrigg J., Hinchliffe R.J. Peripheral arterial disease and revascularization of the diabetic foot // Diabetes Obes Metab. 2015;17:435–444.10.1111/dom.12422Search in Google Scholar

21. Hinchliffe R.J., Andros G., Apelqvist J., Bakker K., Friederichs S., Lammer J., Lepantalo M., Mills J.L., Reekers J., Shearman C.P., Valk G., Zierler R.E., Schaper N.C. A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease. Diabetes Metab Res Rev. 2012;28(Suppl 1):179-217.10.1002/dmrr.2249Search in Google Scholar

22. Cavanagh P., Attinger C., Abbas Z., Bal A., Rojas N., Xu Z.R. Cost of treating diabetic foot ulcers in five different countries. Diabetes Metab Res Rev. 2012;28(Suppl 1):107–111.10.1002/dmrr.2245Search in Google Scholar

23. Morton L.M., Phillips T.J. Wound healing and treating wounds: Differential diagnosis and evaluation of chronic wounds. J Am Acad Dermatol. 2016;74(4):589-605.10.1016/j.jaad.2015.08.068Open DOISearch in Google Scholar

24. Bermudez D.M., Herdrich B.J, Xu J., Lind R., Beason D.P., Mitchell M.E., Soslowsky L.J., Liechty K.W. Impaired biomechanical properties of diabetic skin implications in pathogenesis of diabetic wound complications. Am J Pathol. 2011;178(5):2215-2223.10.1016/j.ajpath.2011.01.015Search in Google Scholar

25. Bainbridge P. Wound healing and the role of fibroblasts. J Wound Care. 2013;22:407-412.10.12968/jowc.2013.22.8.407Search in Google Scholar

26. Lerman O.Z., Galiano R.D., Armour M., Levine J.P., Gurtner G.C. Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol. 2003;162:303–312.10.1016/S0002-9440(10)63821-7Search in Google Scholar

27. Loot MA, Kenter SB, Au FL, van Galen WJ, Middelkoop E, Bos JD, Mekkes JR. Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls. Eur J Cell Biol. 2002;81:153–160.10.1078/0171-9335-0022811998867Search in Google Scholar

28. Lukasheva E.V. Materials for lectures on the biochemistry of connective tissue Moscow: RUDN. 2009. 40 pp. (in Rus)Search in Google Scholar

29. Rennert R.C., Sorkin M., Garg R.K., Januszyk M., Gurtner G.C. Cellular response to a novel fetal acellular collagen matrix: implications for tissue regeneration. Int J Biomater; 2013:527957.10.1155/2013/527957373647423970899Search in Google Scholar

30. Bella J., Hulmes D.J. Fibrillar Collagens. Subcell Biochem. 2017;82:457-490.10.1007/978-3-319-49674-0_1428101870Search in Google Scholar

31. Exposito J.Y., Valcourt U., Cluzel C., Lethias C. The fibrillar collagen family. Int J Mol Sci. 2010;11(2):407–426.10.3390/ijms11020407285284620386646Open DOISearch in Google Scholar

32. Mienaltowski M.J., Birk D.E. Structure, physiology, and biochemistry of collagens. Adv Exp Med Biol. 2014;802:5–29.10.1007/978-94-007-7893-1_224443018Search in Google Scholar

33. Bruckner P. Suprastructures of extracellular matrices: paradigms of functions controlled by aggregates rather than molecules. Cell Tissue Res. 2010;39(1):7–18.10.1007/s00441-009-0864-019756756Open DOISearch in Google Scholar

34. Ishikawa Y., Bachinger H.P. A molecular ensemble in the rER for procollagen maturation. Biochim Biophys Acta. 2013;1833(11):2479–2491.10.1016/j.bbamcr.2013.04.00823602968Open DOISearch in Google Scholar

35. Bekhouche M., Colige A. The procollagen N-proteinases ADAMTS2, 3 and 14 in pathophysiology. Matrix Biol. 2015:44-53.10.1016/j.matbio.2015.04.00125863161Search in Google Scholar

36. Chen S., Birk D.E. The regulatory roles of small leucine- rich proteoglycans in extracellular matrix assembly. FEBS J. 2013;280(10):2120–2137.10.1111/febs.12136365180723331954Search in Google Scholar

37. Kalamajski S., Oldberg A. The role of small leucine-rich proteoglycans in collagen fibrillogenesis. Matrix Biol. 2010;29(4):248–253.10.1016/j.matbio.2010.01.00120080181Open DOISearch in Google Scholar

38. Rosset E.M., Bradshaw A.D. SPARC/osteonectin in mineralized tissue. Matrix Biol. 2016;52:78–87.10.1016/j.matbio.2016.02.001Search in Google Scholar

39. Hamaia S., Farndale R.W. Integrin recognition motifs in the human collagens. Adv Exp Med Biol. 2014;819:127–142.10.1007/978-94-017-9153-3_925023172Search in Google Scholar

40. Heino J. Cellular signaling by collagen-binding integrins. Adv Exp Med Biol. 2014;819:143–155.10.1007/978-94-017-9153-3_1025023173Search in Google Scholar

41. Leitinger B. Transmembrane collagen receptors. Annu Rev Cell Dev Biol. 2011;27:265–290.10.1146/annurev-cellbio-092910-15401321568710Open DOISearch in Google Scholar

42. Chattopadhyay S., Raines R. Collagen-Based Biomaterials for Wound Healing. Biopolymers. 2014;101(8):821-833.10.1002/bip.22486420332124633807Search in Google Scholar

43. Silina EV, Stupin VA, Zolotareva LS, Komarov AN. Native collagen application in clinical practice for chronic wounds treatment. Khirurgiia 2017;9:78-84. doi: 10.17116/hirurgia2017978-84.10.17116/hirurgia2017978-8428914838Open DOISearch in Google Scholar

44. Briskin B. S., Poljanskij M. V., Hramilin V. N. (2008) Application of the bioplastic material Collost in the complex treatment of complicated forms of the diabetic foot syndrome. Sbornik materialov simpoziuma «Diabeticheskaja stopa: hirurgija, terapija, reabilitacija. 3-5 Oct 2008. (in Rus)Search in Google Scholar

45. Parenteau-Bareil R., Gauvin R., Cliche S., Gariépy C., Germain L., Berthod F. Comparative study of bovine, porcine and avian collagens for the production of a tissue engineered dermis. Acta Biomater. 2011;7:3757–3765.10.1016/j.actbio.2011.06.02021723967Open DOISearch in Google Scholar

46. Schönfelder U., Abel M., Wiegand C., Klemm D., Elsner P., Hipler U.C. Influence of selected wound dressings on PMN elastase in chronic wound fluid and their antioxidative potential in vitro. Biomaterials. 2005;26:6664–6673.1597866410.1016/j.biomaterials.2005.04.03015978664Search in Google Scholar

47. Wiegand C., Schönfelder U., Abel M., Ruth P., Kaatz M., Hipler U.C. Protease and pro-inflammatory cytokine concentrations are elevated in chronic compared to acute wounds and can be modulated by collagen type I in vitro. Arch Dermatol Res. 2010;302:419–428.10.1007/s00403-009-1011-120033193Search in Google Scholar

48. Neve A., Cantatore F.P., Maruotti N., Corrado A., Ribatti D. Extracellular matrix modulates angiogenesis in physiological and pathological conditions. BioMed Res Int. 2014:1–10.10.1155/2014/756078405246924949467Search in Google Scholar

49. Volk S.W., Wang Y., Mauldin E.A., Liechty K.W., Adams S.L. Diminished type III collagen promotes myofibroblast differentiation and increases scar deposition in cutaneous wound healing. Cells Tissues Organs. 2011;194:25–37.10.1159/000322399312815721252470Search in Google Scholar

50. Kirsner R.S. Wound iealing. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. 2nd ed. St Louis (MO). Elsevier Health Sciences. 2008;2:2147-2158.Search in Google Scholar

51. Nuutila K., Peura M., Suomela S., Hukkanen M., Siltanen A., Harjula A., Vuola J., Kankuri E. Recombinant human collagen III gel for transplantation of autologous skin cells in porcine full-thickness wounds. J Tissue Eng Regen Med. 2015;12(9):1386-93.10.1002/term.169123362205Search in Google Scholar

52. Edwards J.V,, Howley P., Cohen I.K. et al. In vitro inhibition of human neutrophil elastase by oleic acid albumin formulations from derivatized cotton wound dressings. Int J Pharm. 2004;284:1–12.10.1016/j.ijpharm.2004.06.003Search in Google Scholar

53. Zhu Y.K., Liu X.D., Skold C.M., Umino T., Wang H.J., Spurzem J.R., Kohyama T., Ertl R.F., Rennard S.I. Synergistic neutrophil elastase-cytokine interaction degrades collagen in three-dimensional culture. Am J Physiol Lung Cell Mol Physiol. 2001;28:L868–878.10.1152/ajplung.2001.281.4.L868Search in Google Scholar

54. Tarlton J.F., Munro H.S. Use of modified superabsorbent polymer dressings for protease modulation in improved chronic wound care. Wounds. 2013;25(2):51-57.25867807Search in Google Scholar

55. Karr J.C., Taddei A.R., Picchietti S., Gambellini G., Fausto A.M., Giorgi F. A morphological and biochemical analysis comparative study of the collagen products Biopad, Promogram, Puracol, and Colactive. Adv Skin Wound Care. 2011;24(5):208-216.2150528110.1097/01.ASW.0000397897.18003.ceSearch in Google Scholar

56. Karr J.C. Retrospective comparison of diabetic foot ulcer and venous stasis ulcer healing outcome between a dermal repair scaffold (PriMatrix) and a bilayered living cell therapy (Apligraf). Adv Skin Wound Care. 2011;24(3):119-125.10.1097/01.ASW.0000395038.28398.88Search in Google Scholar

57. Wiegand C., Buhren B.A., Bünemann E., Schrumpf H., Homey B., Frykberg R.G., Lurie F., Gerber P.A. A novel native collagen dressing with advantageous properties to promote physiological wound healing. J Wound Care. 2016; 25(12):713-720.10.12968/jowc.2016.25.12.713Search in Google Scholar

58. Ricci E., Cutting K.F. Evaluating a native collagen matrix dressing in the treatment of chronic wounds of different aetiologies: a case series. J Wound Care. 2016;25(11):670-678.10.12968/jowc.2016.25.11.670Search in Google Scholar

59. Savon I.L. The use of the Colloaut membrane in patients with complicated daibetic foot syndrome. Kharkiv surgical school. 2012; 52(1):123-127.Search in Google Scholar

60. Dibirov M. D., Gadzhimuradov R. U., Koreiba K. A., Minabutdinov A. R. Biomedical Technologies in the Treatment of Skin and Soft Tissue Defects in Patients with Diabetic Foot Syndrome. International Journal of Biomedicine. 2016;6(1):41-45.10.21103/Article6(1)_OA8Open DOISearch in Google Scholar

61. Ivanusa S. Ja., Risman B. V. (2015) Experience with the application of the wound coating “Collost” in the treatment of purulent-necrotic complications of the diabetic foot syndrome. Mezhdunarodnaja nauchnoprakticheskaja konferencija «Mestnoe i medikamentoznoe lechenie ran i gnojno-nekroticheskih ochagov u detej i vzroslyh». Sbornik tezisov. Sochi. 2015. (in Rus)Search in Google Scholar

62. Seliverstov D. V., Novikov L. A., Sazhin V. P., Judin V. A., Kuckir V. G., Kondrus’ I. V., Masevin V. V., Pod#jablonskaja I. A., Savkin I. D. Application of bioplastic collagen material for temporary closure of wound defects and stimulation of reparative processes in purulent-necrotic forms of diabetic foot syndrome. Hirurgicheskaja obrabotka ran i gnojno-nekroticheskih ochagov u detej i vzroslyh. Sbornik tezisov. 2014. P. 210-211. (in Rus)Search in Google Scholar

63. Stupin V. A., Gorjunov S. V., Zhidkih S. Ju., Gorskij V. A., Sivkov A. S., Komarov A. N., Korejba K. A., Bogomolov M. S., Barancevich E. R., Krivihin V. T., Eliseeva M. E., Bakunov M. Ju., Krivihin D. V., Bogdanov E. A., Gabitov R. B., Zolotareva L. S., Silina E. V. Bioplastic collagen colloid material in the treatment of patients with diabetic foot syndrome (results of a multicentre study). Hirurgicheskaja praktika. 2017; 1:5-11. (in Rus)Search in Google Scholar

64. Stupin V. A., Silina E. V., Gorjunov S. V., Gorskij V.A., Krivihin V. T., Bogomolov M. S., Barancevich E. R., Korejba K. A. Assessment of changes in the wound sizes and the incidence of complete epithelialization during the treatment of diabetic foot syndrome over a period of 4 weeks (multicenter study). Khirurgiia. 2017;3:55-60. doi: 10.17116/hirurgia2017355-60.10.17116/hirurgia2017355-6028374714Open DOISearch in Google Scholar

65. Stupin V.A., Silina E.V., Zhidkih S.Y., Gabitov R.B., Bogdanov E.A. Efficiency and safety of collagen biomaterial in treatment of diabetic foot syndrome. Journal of Pharmaceutical Sciences and Research. 2017;9(5):732-736.Search in Google Scholar

66. Driver V.R., Lavery L.A., Reyzelman A.M., Dutra T.G., Dove C.R., Kotsis S.V., Kim H.M., Chung K.C. A clinical trial of Integra Template for diabetic foot ulcer treatment. Wound Repair Regen. 2015;23(6):891-900.10.1111/wrr.1235726297933Search in Google Scholar

67. Komarov A.N., Kezina L.P., Silina E.V., Gabitov R.B., Orlova A.S., Korejba K.A. Clinical efficacy of bioplastic material based on native collagen in the treatment of decubitus in patients in neurorehabilitation: a randomized comparative study. Vestnik vosstanovitel’noj mediciny. 2017;2:74-83.Search in Google Scholar

68. Dibirov M. D., Gadzhimuradov R. U., Poljanskij M. V., Tereshhenko S. A., Kakubava M. R. The effectiveness of ultrasonic cavitation and bioplastic material “collost” in the treatment of purulent-necrotic complications of the diabetic foot syndrome. Khirurg. 2013;9:4-13.Search in Google Scholar

69. Maksimova N.V., Krstich Ju. A., Stupin V.A. Assessment of the clinical and economic effectiveness of the application of the bioplastic material Collost in the treatment of patients with diabetic foot syndrome. Medicinskie tehnologii. 2017;1:59-66.Search in Google Scholar

70. Dibirov M.D., Gadzhimuradov R.U., Korejba K.A. Analysis of the clinical application of the epidermal growth factor eberprot-p and bioplastic colloquial material in the treatment of skin and soft tissue defects in patients with diabetic foot syndrome. Khirurgiia. 2016;3:59-63.10.17116/hirurgia2016359-63Search in Google Scholar

71. Korejba K. A. Surgical treatment of purulent-necrotic complications of the neuropathic form of the diabetic foot syndrome. Prakticheskaja medicina, Hirurgija. 2016; 97(5):34-38.Search in Google Scholar

72. Korejba K.A., Minabutdinov A.R., Korejba E.A. Syndrome of diabetic foot: complex treatment of trophic neuropathic ulcers. Jendokrinologija. 2015;3:56-60.Search in Google Scholar

73. Lobmann R., Zemlin C., Motzkau M., Reschke K., Lehnert H. Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing. J Diabetes Complications. 2006;20(5):329-35.10.1016/j.jdiacomp.2005.08.00716949521Search in Google Scholar

74. Motzkau M, Tautenhahn J, Lehnert H, Lobmann R. Expression of matrix-metalloproteases in the fluid of chronic diabetic foot wounds treated with a protease absorbent dressing. Exp Clin Endocrinol Diabetes. 2011;119(5):286-290.10.1055/s-0030-126723521031342Search in Google Scholar

75. Kakagia DD, Kazakos KJ, Xarchas KC, Karanikas M, Georgiadis GS, Tripsiannis G, Manolas C. Synergistic action of protease-modulating matrix and autologous growth factors in healing of diabetic foot ulcers. A prospective randomized trial. J Diabetes Complications. 2007;21(6):387-391.1796771210.1016/j.jdiacomp.2007.03.00617967712Search in Google Scholar

76. Veves A, Sheehan P, Pham HT. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg. 2002;137(7):822-827.10.1001/archsurg.137.7.82212093340Search in Google Scholar